[Elsevier] Efficacy and safety of co-administered once-weekly cagrilintide 2﹞4 mg with once-weekly semaglutide 2﹞4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial

Ahmed_2 Post time 2026-8-14 02:00:34 | Show all posts |Read mode
This post will be closed automatically in 2026-08-17 01:59
Reward20points

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
trt Post time 2026-8-14 02:00:35 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    0


Return to the list